Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP492073.RArm33SbaV2vTbzjXwctG_HumHYiRmRlY-bP0SUi4nslE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP492073.RArm33SbaV2vTbzjXwctG_HumHYiRmRlY-bP0SUi4nslE130_assertion type Assertion NP492073.RArm33SbaV2vTbzjXwctG_HumHYiRmRlY-bP0SUi4nslE130_head.
- NP492073.RArm33SbaV2vTbzjXwctG_HumHYiRmRlY-bP0SUi4nslE130_assertion description "[We compared the efficacy of gene therapy mediated by interleukin-2 (IL-2) gene-modified tumor cells to gene therapy mediated by IL-2 transduced fibroblasts in the CT-26 model of murine colorectal carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492073.RArm33SbaV2vTbzjXwctG_HumHYiRmRlY-bP0SUi4nslE130_provenance.
- NP492073.RArm33SbaV2vTbzjXwctG_HumHYiRmRlY-bP0SUi4nslE130_assertion evidence source_evidence_literature NP492073.RArm33SbaV2vTbzjXwctG_HumHYiRmRlY-bP0SUi4nslE130_provenance.
- NP492073.RArm33SbaV2vTbzjXwctG_HumHYiRmRlY-bP0SUi4nslE130_assertion SIO_000772 7582256 NP492073.RArm33SbaV2vTbzjXwctG_HumHYiRmRlY-bP0SUi4nslE130_provenance.
- NP492073.RArm33SbaV2vTbzjXwctG_HumHYiRmRlY-bP0SUi4nslE130_assertion wasDerivedFrom befree-20150227 NP492073.RArm33SbaV2vTbzjXwctG_HumHYiRmRlY-bP0SUi4nslE130_provenance.
- NP492073.RArm33SbaV2vTbzjXwctG_HumHYiRmRlY-bP0SUi4nslE130_assertion wasGeneratedBy ECO_0000203 NP492073.RArm33SbaV2vTbzjXwctG_HumHYiRmRlY-bP0SUi4nslE130_provenance.